The effect of NIV or DON on the cell cycle was tested at the concentration of 10 mM

(C) and nuclear (N) fractions of T cells treated as described in A. doi:10.1371/journal.pone.0096695.g006 distributes evenly between the cytosol and the nucleus in the absence of 1,25(OH)2D3, and that 1,25(OH)2D3 facilitates translocation of the VDR to the nucleus [14�17]. It has been suggested that nuclear import of the VDR is important for stabilization of the VDR in osteoblasts [34]. The ubiquitinproteasome pathway is the major route of disposal for most cytosolic and nuclear proteins [64,65]. In agreement, our data demonstrated that human CD4+ T cells contain proteasome activity that degrades the VDR. Blocking proteasome activity increased the VDR levels to the same extent in the cytosol and nucleus. At first sight, this indicated that the VDR is 518303-20-3 cost PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19653943 degraded with similar kinetics in these compartments. However, the VDR most probably rapidly shuttles between the cytosol and the nucleus, and we could therefore not exclude that the VDR mainly is degraded in either the cytosol or the nucleus. To determine where the VDR is degraded, we studied the effect of LMB known to block nuclear export of a series of molecules [66,68]. LMB has previously been reported to block nuclear export of unliganded VDR-GFP chimeras in transfected cell lines [67]; however, we clearly demonstrated that LMB neither inhibits nuclear export nor affects PLOS ONE | www.plosone.org 10 degradation of the VDR in CD4+ T cells. Consequently, we could not determine the primary site for VDR degradation, but we could conclude that 1,25(OH)2D3 inhibits the spontaneous proteasomal degradation of the VDR and thereby increases the half-life of the VDR in CD4+ T cells. These results are in good agreement with previous studies in other cell types, which found that 1,